Novalab Cardiac Diabetic Care Verified

Novalab Cardiac Care (part of Novalab Group / Novalab Healthcare) is an ISO-certified, WHO-GMP approved pharmaceutical division in India that specializes in cardiac and anti-diabetic drug formulations and offers PCD (Propaganda Cum Distribution) pharma franchise opportunities.

Core Offerings & Products

• Therapeutic Range: Focuses on medicines for cardiovascular conditions, hypertension (high blood pressure), cholesterol management, heart attacks, strokes, and Type 1 and Type 2 diabetes mellitus.
• Formulations: Includes tablets, capsules, soft gels, syrups, and injectables (such as Novazdil F, Racecred 100, and Wattag Omega 3).
• Quality Standards: Products comply with ISO, WHO-GMP, DCGI, and FSSAI guidelines.

PCD Franchise & Business Model

• Monopoly Rights: Offers exclusive area-wise monopoly distribution rights to franchise partners so they face no internal brand competition in their assigned region.
• Promotional Support: Provides free promotional and marketing tools like MR bags, visual aids, visiting cards, reminder cards, and diaries.
• Business Opportunity: Designed for low-investment, high-margin local distribution across India